Kohagura, Kentaro
Yamasaki, Hironori
Takano, Hiroki
Ohya, Yusuke
Seino, Yutaka
Article History
Received: 16 December 2019
Revised: 3 February 2020
Accepted: 20 February 2020
First Online: 19 March 2020
Compliance with ethical standards
:
: KK has received speaker’s fees from Nippon Boehringer Ingelheim Co., Ltd, Mitsubishi Tanabe Pharma Co., Ltd, Astellas Pharma Inc., MSD K.K., Ono Pharmaceutical Co., Ltd, AstraZeneca K.K., and Taisho Toyama Pharmaceutical Co., Ltd. YO has received speaker’s fees from Nippon Boehringer Ingelheim Co., Ltd, Takeda Pharmaceutical Co., Ltd, Daiichi Sankyo Pharmaceutical Co., Ltd. YS has received consulting and/or speaker’s fees from MSD K.K., Kao Co., Ltd, Novo Nordisk Pharma Inc., Taisho Pharmaceutical Co., Ltd, Taisho Toyama Pharmaceutical Co., Ltd, Nippon Becton, Dickinson and Company, Nippon Boehringer Ingelheim Co., Ltd, and Takeda Pharmaceutical Co., Ltd. HY and HT are employees of Taisho Pharmaceutical Co., Ltd.